| Bioactivity | PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki value of 7.9 nM. PF-03550096 has analgesic activity[1]. |
| In Vivo | PF-03550096 (3, 10 mg/kg, 口服, 0.5 h) 可抑制 2,4,6-三硝基苯磺酸 (TNBS) 诱导的大鼠结肠痛阈降低[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| CAS | 910376-39-5 |
| Formula | C19H28N4O4 |
| Molar Mass | 376.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kikuchi A, et al. Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity. J Pharmacol Sci. 2008 Feb;106(2):219-24. |
PF-03550096
CAS: 910376-39-5 F: C19H28N4O4 W: 376.45
PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki v
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.